MICHAEL HARRIS: Open Payments
NPI 1366493827 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,154 in 109 payments from 17 companies in 2025. Trend: 2023 $2,397 · 2024 $2,687 · 2025 $2,154
Food & beverage: $2,052Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $359 |
| Vanda Pharmaceuticals Inc. | 9 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $193 |
| Noven Therapeutics, LLC | 11 | $181 |
| Alkermes, Inc. | 9 | $181 |
| Corium, LLC | 10 | $161 |
| Teva Pharmaceuticals USA, Inc. | 4 | $161 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Janssen Pharmaceuticals, Inc | 5 | $114 |
| Lundbeck LLC | 6 | $112 |
Products named: VRAYLAR, REXULTI, CAPLYTA, HETLIOZ, Xelstrym, Azstarys, LYBALVI, Jornay PM.
Industry payments across KY — which companies pay providers there.
